Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FSHPR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 2
  • 0 comments

FSHPR attributes changed: Attr: Fin_status N -> E;

Comment Full text

FSHP attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 2
  • 0 comments

FSHP attributes changed: Attr: Fin_status N -> E;

Comment Full text

FSHPU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 2
  • 0 comments

FSHPU attributes changed: Attr: Fin_status N -> E;

Comment Full text

EXFY attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 2
  • 0 comments

EXFY attributes changed: Attr: Fin_status N -> D;

Comment Full text

ESHAR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 2
  • 0 comments

ESHAR attributes changed: Attr: Fin_status N -> E;

Comment Full text

ESHA attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 2
  • 0 comments

ESHA attributes changed: Attr: Fin_status N -> E;

Comment Full text

CELULARITY INC (CELU)

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 0
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

CELUW attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 0
  • 0 comments

CELUW attributes changed: Attr: Fin_status N -> E;

Comment Full text

CELU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 0
  • 0 comments

CELU attributes changed: Attr: Fin_status N -> E;

Comment Full text

CETY attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 0
  • 0 comments

CETY attributes changed: Attr: Fin_status N -> E;

Comment Full text
  • Previous
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next

Search

News categories

  • Technical Exchange News(12220)
  • Event(6113)
  • SEC News(262590)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(153945)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin